Adams Adrian
SEC-identified person · CIK 1248144 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Talphera, INC. TLPH | Director | filed 2013 - 2026 |
| Akebia Therapeutics, Inc. AKBA | Director | filed 2018 - 2026 |
| IPI Legacy Liquidation Co IMPLQ | Director · COB, CEO and President | filed 2021 - 2023 |
| Aralez Pharmaceuticals Inc. ARLZ | Director · Chief Executive Officer | filed 2016 - 2017 |
| Pozen INC /NC POZN | Director · Chief Executive Officer | filed 2015 - 2015 |
| Auxilium Pharmaceuticals INC AUXL | Director · CEO and President | filed 2011 - 2015 |
| Amylin Pharmaceuticals INC AMLN | Director | filed 2007 - 2012 |
| Neurologix INC/DE NRGX:OB | Director · CEO, CHAIRMAN OF THE BOARD | filed 2011 - 2011 |
| Inspire Pharmaceuticals INC ISPH | Director · President and CEO | filed 2010 - 2011 |
| Sepracor INC /DE/ SEPR | Director · President & COO | filed 2007 - 2009 |
| KOS Pharmaceuticals INC kosp | Director · President & CEO | filed 2006 - 2006 |
| Neurocrine Biosciences INC NBIX | Director | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.